{"id":764581,"date":"2026-07-15T15:33:09","date_gmt":"2026-07-15T15:33:09","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/764581\/"},"modified":"2026-07-15T15:33:09","modified_gmt":"2026-07-15T15:33:09","slug":"cytovance-adds-perfusion-capabilities-contract-pharma","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/764581\/","title":{"rendered":"Cytovance Adds Perfusion Capabilities | Contract Pharma"},"content":{"rendered":"<p class=\"has-cyan-bluish-gray-background-color has-background\">Editor\u2019s Take: This latest investment builds on Cytovance\u2019s recent <a href=\"https:\/\/www.contractpharma.com\/breaking-news\/cytovance-biologics-adds-cell-line-development-services\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">expansion of in-house cell line development<\/a> and <a href=\"https:\/\/www.contractpharma.com\/breaking-news\/cytovance-biologics-expands-services-with-in-house-formulation-development\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">formulation development services<\/a>.<\/p>\n<p><a href=\"https:\/\/cytovance.com\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Cytovance Biologics<\/a>, a U.S.-based contract development and manufacturing organization (CDMO), has expanded its upstream process development offerings with the addition of perfusion capabilities.<\/p>\n<p>\u201cOur goal is to continue expanding the technologies and expertise available to clients as the industry evolves,\u201d said Fuad Haddadin, Ph.D., Head of Research &amp; Development at Cytovance Biologics. \u201cBy integrating perfusion into our development platform, we\u2019re giving sponsors greater flexibility while positioning Cytovance to support the future of biologics manufacturing.\u201d<\/p>\n<p>Unlike traditional fed-batch processes, perfusion continuously replenishes fresh media while removing spent media, allowing cell cultures to remain healthy and productive for significantly longer periods. The approach can improve productivity, maintain more consistent culture conditions, and reduce the accumulation of metabolic byproducts that may impact product quality.<\/p>\n<p>The addition of perfusion capabilities enables Cytovance to support clients evaluating different upstream manufacturing strategies for monoclonal antibodies, recombinant proteins, and other biologic modalities, particularly during early process development.<\/p>\n<p>\u201cPerfusion is not intended to replace fed-batch manufacturing; it\u2019s another tool that allows us to develop the right process for each client\u2019s program,\u201d said Charles Oluremi Solanke, Senior Scientist, Upstream Process Development at Cytovance Biologics. \u201cBy expanding our expertise in both approaches, we\u2019re able to help companies optimize productivity, improve process consistency, and prepare programs for long-term manufacturing success.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Editor\u2019s Take: This latest investment builds on Cytovance\u2019s recent expansion of in-house cell line development and formulation development&hellip;\n","protected":false},"author":2,"featured_media":764582,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[4,450,451,3,452,453],"class_list":["post-764581","post","type-post","status-publish","format-standard","has-post-thumbnail","category-breaking-news","tag-breaking-news","tag-breakingnews","tag-headlines","tag-news","tag-top-stories","tag-topstories"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/764581","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=764581"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/764581\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/764582"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=764581"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=764581"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=764581"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}